Search
Search Results
##search.searchResults.foundPlural##
-
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3502PDF: 834HTML: 6695 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1216PDF: 514HTML: 22993 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2434PDF: 817HTML: 8790Efremov 1: 205Efremov 2: 165 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
974PDF: 974HTML: 87 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6744PDF: 3834HTML: 24848 -
Acquired Hemophilia A successfully treated with rituximab
1850PDF: 1094HTML: 1443Figure 1: 151 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1871PDF: 707HTML: 678 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3623PDF: 1207HTML: 3863Untitled: 190Untitled: 241 -
How I treat acute and persistent sickle cell pain
1836PDF: 1087HTML: 460 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3167PDF: 1191HTML: 8082 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1692PDF: 502HTML: 16958Figure 4: 144Figure 3: 125Figure 2: 124Figure 1: 154 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1130PDF: 806HTML: 3343 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1554PDF: 767HTML: 1219Figure 1: 151Figure 2: 168Figure 3: 165 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1974PDF: 1461HTML: 259 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
807PDF: 477HTML: 1284 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1242PDF: 775HTML: 114 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1999PDF: 904HTML: 280 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1214PDF: 878HTML: 280 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2314PDF: 888HTML: 486 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5942PDF: 3125HTML: 8989Figure Malaria Ricci: 207 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1024PDF: 524HTML: 1676Figures: 147Fifures Sanz: 157tables Sanz: 163Untitled: 158 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3957PDF: 1895HTML: 5192Table 1: 166 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1204PDF: 945HTML: 310 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2808PDF: 1312HTML: 3551Untitled: 171Untitled: 186Untitled: 162 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3158PDF: 1300HTML: 4104







